Therapeutic Opportunities in Neurodegenerative Disease
	Cold Spring Harbor Laboratory , Cold Spring Harbor, NY November 30 - December 3, 2000
	Confirmed Speakers: Andrea Califano, IBM Dennis Choi, Washington University Mel Feaney, Harvard Medical School Kevin Felsenstein, Bristol Myers Squibb Mark Gurney, Pharmacia Upjohn Michael Hutton, The Mayo Clinic Ron McKay, NIH Nick Mazarakis, Oxford Biomedica Inc. Anne Murphy, Mitokor, Inc. Suzette Priola, Rocky Mountain Labs Sophie Roy, Merck Frosst Russell Rydel, Elan Pharmaceuticals Mary Sano, Columbia University Dennis Selkoe, Harvard Medical School Robin Sherrington, Parke-Davis Sukanto Sinha, Elan Pharmaceuticals Li-Huei Tsai, Harvard Medical School Huda Zoghbi, HHMI/ Baylor College of Medicine
	Organized by:	Sam Gandy, New York University, Harry LeVine III, Warner-Lambert/Parke-Davis, Marcy MacDonald, Massachusetts General Hospital/Harvard Medical School
	Invited Speakers:	Proposed Topics: Triplet Repeat Diseases, Tauopathies & Synucleinopathies Cerebral Amyloidoses Amyotrophic Lateral Sclerosis Mechanisms of Neurodegeneration Current Therapies and Prevention Cell and Gene Transfer Genetics, Genomics & Patient selection
	Deadline for Abstracts:	September 27
	Registration:	Register online
	Email for Requests and Registration:	Meetings@cshl.org
	Posted by: Michael Glaessgen   Host: talon.cshl.org date: June 14, 2000 16:44:39 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.